Asymmetric peptide dendrimers are effective linkers for antibody-mediated delivery of diverse payloads to b cells in vitro and in vivo.
OBJECTIVE
Safe, targeted delivery of therapeutics remains a focus of drug/gene delivery, the aim being to achieve optimal efficacy while minimising off-target delivery. Dendrimers have a vast array of potential applications and have great potential as gene and drug delivery tools. We previously reported the development of peptide dendrimers that effectively complexed DNA and that have distinct advantages over conventional spherical dendrimers. Here, to expand the application of peptide-based low generation dendrimers we tested their capacity to be transformed into linkers for antibody-based targeting of diverse payloads.


METHODS
Peptide-based low-generation asymmetric dendrimers were generated and conjugated to partially-reduced antibodies specific for B cell surface antigens or an irrelevant antigen. Preservation of antigen binding by the antibodies and targeting of the conjugated dendrimers carrying a small molecule (biotin) or plasmid DNA payloads was tested.


RESULTS
Peptide-based low generation dendrimers were efficiently and site-specifically conjugated to antibodies with retention of antigen-binding capacity. Altering the branching termini of dendrimers facilitated delivery of diverse payloads in vitro and in vivo.


CONCLUSIONS
We propose that safe, non-toxic peptide dendrimers, which are readily synthesised and modifiable for a variety of applications, form the basis of a new family of biocompatible "linkers" with substantial potential for targeted delivery applications.
UQ Diamantina Institute, The University of Queensland, TRI, 37 Kent St,Woolloongabba, 4102, Queensland, Australia.
Neha D
ND
Shah
Harendra S
HS
Parekh
Raymond J
RJ
Steptoe
D000906:Antibodies / Q000008:administration & dosage* / Q000737:chemistry*; D001402:B-Lymphocytes / Q000187:drug effects*; D004247:DNA / Q000737:chemistry; D050091:Dendrimers / Q000008:administration & dosage* / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods; D010455:Peptides / Q000008:administration & dosage* / Q000737:chemistry*; D010957:Plasmids / Q000737:chemistry
D000906:Antibodies; D050091:Dendrimers; D010455:Peptides; D004247:DNA